Reviewed by Michael Gill, B. Sc.
12 Juvenile Idiopathic Arthritis Clinical Trials Near Me
Top Hospitals for Juvenile Idiopathic Arthritis Clinical Trials
Image of Childrens Hospital Los Angeles in California.
Childrens Hospital Los Angeles
Los Angeles
2Active Trials
2All Time Trials for Juvenile Idiopathic Arthritis
2022First Juvenile Idiopathic Arthritis Trial
Image of Cincinnati Children's Hospital Medical Center in Ohio.
Cincinnati Children's Hospital Medical Center
Cincinnati
2Active Trials
9All Time Trials for Juvenile Idiopathic Arthritis
1994First Juvenile Idiopathic Arthritis Trial
Top Cities for Juvenile Idiopathic Arthritis Clinical Trials
Image of Chicago in Illinois.
Chicago
12Active Trials
Northwestern University Feinberg School of Medicine Ann & Robert H Lurie Children's HospitalTop Active Site
Image of Cincinnati in Ohio.
Cincinnati
9Active Trials
Cincinnati Children's Hospital Medical CenterTop Active Site
Juvenile Idiopathic Arthritis Clinical Trials by Phase of Trial
Phase 1 Juvenile Idiopathic Arthritis Clinical Trials
2Active Juvenile Idiopathic Arthritis Clinical Trials
2Number of Unique Treatments
16Number of Active Locations
Juvenile Idiopathic Arthritis Clinical Trials by Age Group
Most Recent Juvenile Idiopathic Arthritis Clinical Trials
Top Treatments for Juvenile Idiopathic Arthritis Clinical Trials
Treatment Name
Active Juvenile Idiopathic Arthritis Clinical Trials
All Time Trials for Juvenile Idiopathic Arthritis
First Recorded Juvenile Idiopathic Arthritis Trial
Ustekinumab
2
2
2022
Methotrexate
1
6
2000
Abatacept Injection
1
1
2019
Online aerobic dance training (Group B)
1
1
2019
Upadacitinib
1
2
2019

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 17th, 2021

Last Reviewed: November 13th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30. https://pubmed.ncbi.nlm.nih.gov/189296862 Efird J. Blocked randomization with randomly selected block sizes. Int J Environ Res Public Health. 2011 Jan;8(1):15-20. doi: 10.3390/ijerph8010015. Epub 2010 Dec 23. https://pubmed.ncbi.nlm.nih.gov/213180113 Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004 Feb;31(2):390-2. https://pubmed.ncbi.nlm.nih.gov/147608124 Ford I, Norrie J. Pragmatic Trials. N Engl J Med. 2016 Aug 4;375(5):454-63. doi: 10.1056/NEJMra1510059. https://pubmed.ncbi.nlm.nih.gov/275186635 Ford I, Norrie J. Pragmatic Trials. N Engl J Med. 2016 Aug 4;375(5):454-63. doi: 10.1056/NEJMra1510059. https://pubmed.ncbi.nlm.nih.gov/275186636 Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Martini A, Rabinovich CE, Ruperto N. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011 Apr;63(4):465-82. doi: 10.1002/acr.20460. Review. https://pubmed.ncbi.nlm.nih.gov/214522607 Leu JH, Shiff NJ, Clark M, Bensley K, Lomax KG, Berezny K, Nelson RM, Zhou H, Xu Z. Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations. Paediatr Drugs. 2022 Sep 28. doi: 10.1007/s40272-022-00533-y. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/361715158 Leu JH, Shiff NJ, Clark M, Bensley K, Lomax KG, Berezny K, Nelson RM, Zhou H, Xu Z. Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations. Paediatr Drugs. 2022 Nov;24(6):699-714. doi: 10.1007/s40272-022-00533-y. Epub 2022 Sep 28. https://pubmed.ncbi.nlm.nih.gov/361715159 Ruperto N, Brunner HI, Tzaribachev N, Vega-Cornejo G, Louw I, Cimaz R, Dare J, Espada G, Faugier E, Ferrandiz M, Gerloni V, Quartier P, Silva CA, Wagner-Weiner L, Gandhi Y, Passarell J, Nys M, Wong R, Martini A, Lovell DJ; Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO). Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. J Rheumatol. 2021 Jul;48(7):1073-1081. doi: 10.3899/jrheum.200154. Epub 2021 Jan 15. https://pubmed.ncbi.nlm.nih.gov/3345217310 Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med. 1992 Apr 16;326(16):1043-9. https://pubmed.ncbi.nlm.nih.gov/1549149